Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
Insmed (INSM) Tops Q2 EPS by 9c
August 4, 2022 7:35 AM EDTInsmed (NASDAQ: INSM) reported Q2 EPS of ($0.80), $0.09 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $65.2 million versus the consensus estimate of $58.79 million.
As of June 30, 2022, Insmed had cash and cash equivalents and marketable securities of $564.6 million. The... More
